Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

SZSE:002323
SZSE:002323Electrical

Asian Market Gems: Penny Stocks To Watch In November 2025

As the Asian markets navigate a landscape shaped by global economic shifts, including a temporary U.S.-China trade truce and steady interest rates in major economies like Japan, investors are keenly observing how these developments influence regional equities. Penny stocks, often associated with smaller or emerging companies, continue to attract attention for their potential to offer growth opportunities at accessible price points. Despite their vintage label, these stocks can present...
NasdaqGS:BRY
NasdaqGS:BRYOil and Gas

Berry (BRY): One-Off $3.9M Loss Challenges Bull Case on Margin-Led Growth

Berry (BRY) has become profitable over the past five years, reporting an average earnings growth of 41.6% per year. Looking ahead, earnings are expected to surge another 159.2% annually, but revenue is forecast to decline at an average pace of -1.1% per year for the next three years. The company also recorded a one-off loss of $3.9 million in the most recent financial year, tempering the near-term earnings outlook. Investors will be weighing this mix of rapid projected earnings growth and...
ASX:TNY
ASX:TNYInteractive Media and Services

3 ASX Penny Stocks With Market Caps Under A$200M

Australian shares are poised for a rebound, with futures indicating a positive open as local investors take cues from Wall Street's recent gains. For those interested in exploring smaller or newer companies, penny stocks—despite their somewhat dated terminology—continue to offer intriguing opportunities. By focusing on firms with solid financial foundations and potential for growth, investors may uncover valuable prospects within the realm of penny stocks.
NasdaqGM:AVDL
NasdaqGM:AVDLPharmaceuticals

Avadel Pharmaceuticals (AVDL): Revenue Forecast to Grow 15.6% Annually Heading Into Earnings Season

Avadel Pharmaceuticals (AVDL) continues to operate at a loss, with losses having grown at an average annual rate of 12.4% over the past five years and a net profit margin that remains unimproved year over year. Despite its current lack of profitability, Avadel’s revenue is forecast to climb 15.6% annually, which is ahead of the broader US market’s 10.5%. Earnings are projected to surge by 40.12% each year. The company is anticipated to reach profitability within three years, and with its...
NasdaqGS:CNTA
NasdaqGS:CNTABiotechs

Centessa Pharmaceuticals (CNTA): Rapid 74.3% Revenue Growth Challenges Profitability Concerns

Centessa Pharmaceuticals (CNTA) is forecast to deliver stellar annual revenue growth of 74.3%, far surpassing the broader US market’s 10.5% pace. Despite the robust top-line outlook, the company remains unprofitable and is expected to continue operating at a loss over the next three years. While losses have narrowed at an average rate of 4.3% per year over the past five years, there are no signs of an imminent shift toward profitability. This raises the stakes for investors weighing rapid...
NYSE:MRC
NYSE:MRCTrade Distributors

MRC Global (MRC) Net Margin Decline Raises Questions on Premium Valuation and Turnaround Narrative

MRC Global (MRC) has delivered a notable turnaround, with earnings climbing at an annual rate of 76% over the past five years and forecasts pointing to ongoing 20% per year growth, well above the broader US market’s 16% outlook. Despite the positive trajectory, revenue growth is expected to trail at 3.9% per year compared to a 10.5% pace for the US market, and net profit margins recently slipped from 2.7% to 1.1%. The stock’s price-to-earnings ratio sits at 36.6x, considerably above peers and...
NasdaqGS:ODP
NasdaqGS:ODPSpecialty Retail

ODP (ODP) Net Margin Falls to 0.7%: One-Off Loss Challenges Bull Case

ODP (ODP) reported a net profit margin of 0.7%, down from 2% a year ago, as a one-off loss of $107.0 million weighed on performance over the last twelve months. While the company has averaged 12.3% annual earnings growth since turning profitable, upcoming years are expected to bring a 2.5% annual revenue decline. Investors now face a mixed picture, with ongoing margin pressure and the recent one-off loss on one side, but relative value compared to peers providing a potential bright spot. See...
TSX:BEP.UN
TSX:BEP.UNRenewable Energy

Brookfield Renewable (TSX:BEP.UN): Is Recent Momentum Justified by Current Valuation?

Brookfield Renewable Partners (TSX:BEP.UN) has seen its shares move higher over the past month, supported by steady revenue growth and a significant jump in net income. Investors are watching the stock’s performance as renewables continue to receive attention. See our latest analysis for Brookfield Renewable Partners. Brookfield Renewable Partners’ recent rally has pushed its share price up nearly 12% over the past month, adding to a sharp 28% gain year to date. The company’s total...
NasdaqCM:AEYE
NasdaqCM:AEYESoftware

AudioEye (AEYE) Trades Below Fair Value, Revenue Outlook Tops Market Narratives

AudioEye (AEYE) remains unprofitable but has steadily narrowed its losses over the last five years at an annual rate of 18.4%. Revenue is now forecast to grow 11.5% per year, topping the US market average of 10.5%, even as net profit margins are yet to turn positive. Investors weighing the numbers will note that the company is valued at a 4.7x Price-to-Sales ratio and currently trades at $14.43, below the estimated fair value of $16.72. This keeps the spotlight on its growth prospects and...